COR2ED The Heart of Medical Education
Our COR2ED channel brings together world-renowned medical experts to discuss and provide clear guidance on the latest scientific and clinical insights in various therapeutic areas, including oncology, cardiology, hemostasis, rare diseases, hemato-oncology, and endocrinology. At COR2ED, we are committed to providing balanced and evidence-based independent medical education to support healthcare ...
read more ↘
read more ↘
Video Player is loading.
10 seconds
Playback speed
Diagnosis and Management of mPDAC
This video, developed by Prof. Efrat Dotan and Prof. Shubham Pant, discusses the diagnosis and management of metastatic pancreatic ductal adenocarcinoma (PDAC), a lethal disease which is usually diagnosed at an advanced stage and has an extremely poor diagnosis.
Topics covered in this video include:
• The most reported symptoms
• Different risk factors and main diagnostic tools
• Overview of treatments available
• Considerations for treatment selection
• Targeted therapy
Download the slides and summary flashcard and access the accredited e-learning here: https://cor2ed.com/gi-connect/programmes/metastatic-pancreatic-ductal-adenocarcinoma-pdac/?media=0
Key clinical takeaways:
• Pancreatic ductal adenocarcinoma (PDAC) is usually diagnosed at an advanced, incurable stage due to non-specific symptoms and has an extremely poor prognosis
• Recognition of symptoms and known risk factors is important for an early diagnosis
• Systemic chemotherapy is the standard treatment for mPDAC but molecularly targeted treatments and immunotherapies may have a role for specific patients
• Choice of treatment depends on several factors, including patients' performance status and co-morbidities
Topics covered in this video include:
• The most reported symptoms
• Different risk factors and main diagnostic tools
• Overview of treatments available
• Considerations for treatment selection
• Targeted therapy
Download the slides and summary flashcard and access the accredited e-learning here: https://cor2ed.com/gi-connect/programmes/metastatic-pancreatic-ductal-adenocarcinoma-pdac/?media=0
Key clinical takeaways:
• Pancreatic ductal adenocarcinoma (PDAC) is usually diagnosed at an advanced, incurable stage due to non-specific symptoms and has an extremely poor prognosis
• Recognition of symptoms and known risk factors is important for an early diagnosis
• Systemic chemotherapy is the standard treatment for mPDAC but molecularly targeted treatments and immunotherapies may have a role for specific patients
• Choice of treatment depends on several factors, including patients' performance status and co-morbidities
Comments 0
Login to view comments.
Click here to Login
